The results obtained led to the identification of a pathogenic mutation of a gene that intervenes in the MEF2A signaling pathway, involved in the etiopathogenesis of familial vascular disease associated with CAD/MI [60]. This evidence concerns the gene MEF2A and coronary artery disorder.